Bone fracture healing: cell therapy in delayed unions and nonunions.

Abstract

Bone fracture healing impairment related to mechanical problems has been largely corrected by advances in fracture management. Better protocols, more strict controls of time and function, and hardware and surgical technique evolution have contributed to better prognosis, even in complex fractures. However, atrophic nonunion persists in clinical cases where, for different reasons, the osteogenic capability is impaired. When this is the case, a better understanding of the basic mechanisms under bone repair and augmentation techniques may put in perspective the current possibilities and future opportunities. Among those, cell therapy particularly aims to correct this insufficient osteogenesis. However, the launching of safe and efficacious cell therapies still requires substantial amount of research, especially clinical trials. This review will envisage the current clinical trials on bone healing augmentation based on cell therapy, with the experience provided by the REBORNE Project, and the insight from investigator-driven clinical trials on advanced therapies towards the future. This article is part of a Special Issue entitled Stem Cells and Bone.

• Authors: Enrique Gómez-Barrena, Philippe Rosset, Daniel Lozano, Julien Stanovici, Christian Ermthaller, Florian Gerbhard
• Journal: Bone (Bone) Vol. 70 Pg. 93-101 (Jan 2015) ISSN: 1873-2763 [Electronic] United States
• PMID: 25093266 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
• Copyright: Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Chemical References

• Biocompatible Materials

Topics

• Biocompatible Materials (pharmacology)
• Clinical Trials as Topic
• Fracture Healing (drug effects)
• Fractures, Ununited (therapy)
• Humans
• Stem Cell Transplantation